RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Qsam Biosciences Stock

Qsam Biosciences Net Income 2024

Qsam Biosciences Net Income

-6.07 M USD

Ticker

QSAM

ISIN

US74738N1037

WKN

A2QERD

In 2024, Qsam Biosciences's profit amounted to -6.07 M USD, a -55.18% increase from the -13.55 M USD profit recorded in the previous year.

The Qsam Biosciences Net Income history

YEARNET INCOME (undefined USD)
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-

Qsam Biosciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Qsam Biosciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Qsam Biosciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Qsam Biosciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Qsam Biosciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Qsam Biosciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Qsam Biosciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Qsam Biosciences’s growth potential.

Qsam Biosciences Revenue, EBIT and net profit per share

DateQsam Biosciences RevenueQsam Biosciences EBITQsam Biosciences Net Income
20220 undefined-5.46 M undefined-6.07 M undefined
20210 undefined-11.04 M undefined-13.55 M undefined
20200 undefined-1.32 M undefined-4.9 M undefined
20190 undefined-1.13 M undefined-717,980 undefined
201833,330 undefined-1.58 M undefined-438,030 undefined
201774,760 undefined-1.33 M undefined-2.75 M undefined
201640,000 undefined-2.05 M undefined-1.53 M undefined
201520,000 undefined-3.38 M undefined-3.54 M undefined

Qsam Biosciences stock margins

The Qsam Biosciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Qsam Biosciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Qsam Biosciences.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Qsam Biosciences's sales revenue. A higher gross margin percentage indicates that the Qsam Biosciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Qsam Biosciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Qsam Biosciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Qsam Biosciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Qsam Biosciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Qsam Biosciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Qsam Biosciences Margin History

Qsam Biosciences Gross marginQsam Biosciences Profit marginQsam Biosciences EBIT marginQsam Biosciences Profit margin
2022100 %0 %0 %
2021100 %0 %0 %
2020100 %0 %0 %
2019100 %0 %0 %
2018100 %-4,733.63 %-1,314.22 %
201715.33 %-1,772.5 %-3,678.57 %
201682.08 %-5,118.28 %-3,834.1 %
201571 %-16,924 %-17,700.25 %

Qsam Biosciences Aktienanalyse

What does Qsam Biosciences do?

Qsam Biosciences Inc. is a pharmaceutical and biotechnology company specializing in the development and marketing of innovative medicines and diagnostics. The company was founded in 2004 by a group of scientists with the goal of developing innovative and effective therapies for various diseases. The business model of Qsam Biosciences is based on close collaboration between experts in molecular biology, biochemistry, biophysics, and pharmacology. State-of-the-art technologies and methods are used to explore new drugs, characterize their pharmacological effects, and test their efficacy and safety in rigorous clinical trials. A particular focus is on the development of therapies for cancer, autoimmune diseases, and neurodegenerative diseases such as Alzheimer's and Parkinson's. Qsam Biosciences already has promising candidates in its pipeline, which are being tested in phase 2 and phase 3 studies. In addition to developing new drugs, Qsam Biosciences also operates a diagnostics division that focuses on developing new test methods for early detection of diseases. Molecular diagnostic methods are particularly used to detect diseases such as cancer, cardiovascular diseases, and infectious diseases at an early stage. Among Qsam Biosciences' key products are a range of antibodies and protein inhibitors that specifically target disease-specific targets, demonstrating high efficacy and precision. These drugs are used both as monotherapy and in combination with other medications to ensure optimal treatment. One particular highlight is the drug QB-101, currently being developed for the treatment of Parkinson's disease. QB-101 is a novel protein inhibitor that specifically inhibits the activity of dopamine-degrading enzymes, reducing dopamine breakdown in the brain. QB-101 has already shown promising results in clinical trials and is currently being tested in a large phase 2 study. Overall, Qsam Biosciences is an innovative and dynamic company that makes a significant contribution to the fight against serious diseases with its products and services. With the use of state-of-the-art technologies and methods, as well as close collaboration between experts from different disciplines, Qsam Biosciences is well positioned to develop effective medicines and diagnostics that can improve and prolong patients' lives. Qsam Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Qsam Biosciences's Profit Margins

The profit margins of Qsam Biosciences represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Qsam Biosciences's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Qsam Biosciences's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Qsam Biosciences's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Qsam Biosciences’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Qsam Biosciences stock

How much profit has Qsam Biosciences made this year?

Qsam Biosciences has made -6.07 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -55.18% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Qsam Biosciences publish its earnings?

Qsam Biosciences publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Qsam Biosciences?

The profits of Qsam Biosciences are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Qsam Biosciences?

You can learn more about the earnings of Qsam Biosciences by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Qsam Biosciences pay?

Over the past 12 months, Qsam Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Qsam Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Qsam Biosciences?

The current dividend yield of Qsam Biosciences is .

When does Qsam Biosciences pay dividends?

Qsam Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Qsam Biosciences?

Qsam Biosciences paid dividends every year for the past 0 years.

What is the dividend of Qsam Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Qsam Biosciences located?

Qsam Biosciences is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Qsam Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Qsam Biosciences from 9/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Qsam Biosciences pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of Qsam Biosciences in the year 2023?

In the year 2023, Qsam Biosciences distributed 0 USD as dividends.

In which currency does Qsam Biosciences pay out the dividend?

The dividends of Qsam Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Qsam Biosciences

Our stock analysis for Qsam Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Qsam Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.